Actively Recruiting
Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
Led by Guangzhou 8th People's Hospital · Updated on 2023-11-24
60
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observing the Real-World Application Effectiveness of Cytokine Immune Adsorption Technology in AIDS Patients with Severe Pneumonia or septic shock.
CONDITIONS
Official Title
Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed HIV infection
- Progression to AIDS stage with CD4+ count less than 200 cells/ul and/or AIDS opportunistic infections
- Age between 18 and 65 years
- Diagnosis of severe pneumonia based on 2021 ATS and IDSA guidelines or septic shock based on Chinese Guidelines for Emergency Treatment of Sepsis/Septic Shock (2018)
You will not qualify if you...
- Central nervous system lesions, severe liver disease, or cirrhosis
- Concurrent AIDS-related or unrelated tumors
- Women who are pregnant or breastfeeding
- Severe underlying diseases of the heart, lungs, liver, or kidneys
- Alcohol abuse or drug use
- Condition that affects evaluation or completion of the trial as judged by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Guangzhou, Guangdong, China, 510060
Actively Recruiting
Research Team
L
Linghua Li, PhD
CONTACT
Y
Yaozu He, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here